SMSbiotech, founded in 2015, is a pre-clinical, late-stage biotech company. Through a combination of hard work and many decades of experience in research and applications, we have introduced a new proprietary technology that will change how the life science industry approaches the research of cells, drugs, and toxins. Based on our patented, revolutionary, adult stem cell research technologies, new potential treatments can be tested earlier than with traditional methods, and cost-effectively.
The SMSbiotech platform technology will penetrate the regenerative medicine and bio-manufacturing markets and lay the groundwork for developing alternative, more efficient, and relevant treatments and medications.
We believe that we are only as strong as our team. We have undergone several collaborations with scientific institutions and leading research organizations. We strive to hire and consult with people who share our vision and dedication.
Do you want to learn more about us? Contact us!